Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Hock

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Pharmacological Research Communications|March 1, 1985
Beneficial effects of a neutral protease inhibitor in traumatic shockC E Hock, A M Lefer
Research Communications in Chemical Pathology and Pharmacology|June 1, 1986
CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusionC E Hock, A M Lefer
Circulatory Shock|January 1, 1985
Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shockC E Hock, A M Lefer
Circulatory Shock|January 1, 1984
Beneficial effect of a thromboxane synthetase inhibitor in traumatic shockC E Hock, A M Lefer
Peptides|May 1, 1985
Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shockC E Hock, A M Lefer
Life Sciences|November 25, 1985
Mechanisms mediating canine renal vasoconstriction induced by nicotine infusionC E Hock, J C Passmore
Shock (Augusta, Ga.)|September 4, 2001
Inhibition of nitric oxide synthesis by L-name exacerbates acute lung injury induced by hepatic ischemia-reperfusionP Liu, B Xu, C E Hock
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1989
Localization of beta-endorphin in the rat heart and modulation by testosteroneL J Forman, S Estilow, C E Hock
Prostaglandins|October 1, 1984
Inhibitors of lipoxygenase products improve survival in traumatic shockC E Hock, L Loprest, A M Lefer
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1984
Beneficial effect of anisodamine in hemorrhagic shockJ Su, C E Hock, A M Lefer
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Pharmacological Research Communications|March 1, 1985
Beneficial effects of a neutral protease inhibitor in traumatic shockC E Hock, A M Lefer
Research Communications in Chemical Pathology and Pharmacology|June 1, 1986
CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusionC E Hock, A M Lefer
Circulatory Shock|January 1, 1985
Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shockC E Hock, A M Lefer
Circulatory Shock|January 1, 1984
Beneficial effect of a thromboxane synthetase inhibitor in traumatic shockC E Hock, A M Lefer
Peptides|May 1, 1985
Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shockC E Hock, A M Lefer
Life Sciences|November 25, 1985
Mechanisms mediating canine renal vasoconstriction induced by nicotine infusionC E Hock, J C Passmore
Shock (Augusta, Ga.)|September 4, 2001
Inhibition of nitric oxide synthesis by L-name exacerbates acute lung injury induced by hepatic ischemia-reperfusionP Liu, B Xu, C E Hock
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1989
Localization of beta-endorphin in the rat heart and modulation by testosteroneL J Forman, S Estilow, C E Hock
Prostaglandins|October 1, 1984
Inhibitors of lipoxygenase products improve survival in traumatic shockC E Hock, L Loprest, A M Lefer
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1984
Beneficial effect of anisodamine in hemorrhagic shockJ Su, C E Hock, A M Lefer
Pageof 5